Your browser doesn't support javascript.
loading
Successful multimodality treatment for advanced hepatocellular carcinoma with tumor thrombosis of the main portal trunk: a case study.
Kosaka, Yumi; Kawaoka, Tomokazu; Ogawa, Yutaro; Amioka, Kei; Naruto, Kensuke; Yoshikawa, Yuki; Ando, Yuwa; Suehiro, Yosuke; Yamaoka, Kenji; Fujii, Yasutoshi; Uchikawa, Shinsuke; Ono, Atsushi; Yamauchi, Masami; Imamura, Michio; Chosa, Keigo; Awai, Kazuo; Nagata, Yasushi; Chayama, Kazuaki; Aikata, Hiroshi.
Afiliación
  • Kosaka Y; Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8551, Japan.
  • Kawaoka T; Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8551, Japan.
  • Ogawa Y; Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8551, Japan.
  • Amioka K; Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8551, Japan.
  • Naruto K; Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8551, Japan.
  • Yoshikawa Y; Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8551, Japan.
  • Ando Y; Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8551, Japan.
  • Suehiro Y; Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8551, Japan.
  • Yamaoka K; Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8551, Japan.
  • Fujii Y; Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8551, Japan.
  • Uchikawa S; Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8551, Japan.
  • Ono A; Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8551, Japan.
  • Yamauchi M; Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8551, Japan.
  • Imamura M; Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8551, Japan.
  • Chosa K; Diagnostic Radiology, Hiroshima University, Hiroshima, Japan.
  • Awai K; Diagnostic Radiology, Hiroshima University, Hiroshima, Japan.
  • Nagata Y; Therapeutic Radiology, Institute and Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan.
  • Chayama K; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.
  • Aikata H; Institute of Physical and Chemical Research (RIKEN) Center for Integrative Medical Sciences, Yokohama, Japan.
Clin J Gastroenterol ; 14(5): 1517-1524, 2021 Oct.
Article en En | MEDLINE | ID: mdl-34291386
ABSTRACT
The overall survival of patients with advanced hepatocellular carcinoma with tumor thrombosis of the main trunk or bilobar branches of the portal vein is extremely poor. Moreover, there is no standard treatment established for the condition. Herein, we present the case of a 65-year-old man who were treated the patient with hepatic arterial infusion chemotherapy, radiation therapy for tumor thrombosis, portal vein stent placement, lenvatinib administration, and renal venous shunt embolization. A complete response was observed according to mRECIST and the patient has been alive for 14 months since treatment initiation with no tumor recurrence.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trombosis / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Etiology_studies Límite: Aged / Humans / Male Idioma: En Revista: Clin J Gastroenterol Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trombosis / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Etiology_studies Límite: Aged / Humans / Male Idioma: En Revista: Clin J Gastroenterol Año: 2021 Tipo del documento: Article País de afiliación: Japón